The American Society of Plastic Surgeons has recommended that gender-affirming surgeries for minors be delayed until patients reach the age of 19, marking a significant shift in its policy amidst ongoing national debates on this contentious issue, reports BritPanorama.
On Tuesday, the society stated it found “insufficient evidence” that the advantages of chest, genital, and facial surgeries for minors experiencing gender dysphoria outweigh potential risks. This position is informed by recently published studies, including the UK’s Cass Review and a 2025 report from the U.S. Department of Health and Human Services.
The group’s official statement emphasized that it does not seek to undermine the emotional distress of affected patients. It asserted that ethical care for children and adolescents must balance compassion with scientific validation, developmental considerations, and a focus on long-term well-being.
While the society stressed that their statement is not a formal clinical guideline and did not involve an independent evidence assessment, others in the medical community remain steadfast in their recommendations regarding surgery for minors. They maintain that current guidelines emphasize caution and individualized care in these cases.
Other medical groups stand by their guidance
This policy alteration occurs as the Trump administration continues to exert pressure on healthcare providers to limit or cease gender-affirming care, particularly for children. Deputy Health Secretary Jim O’Neill hailed the surgeons’ statement, declaring it a “victory for biological truth” and calling on all provider groups to adopt similar standards.
Despite the ASPS’s changing stance, other prominent medical associations reaffirm their existing guidelines, which advocate for careful consideration of surgeries for young patients. The American Academy of Pediatrics noted that it does not support blanket recommendations for surgery in this demographic, arguing that decisions should be made collaboratively by patients, families, and healthcare providers.
Hospitals halt gender-affirming care for kids
Hospitals nationwide have begun to halt gender-affirming care for minors amid federal threats. Recently, Children’s Minnesota announced it would pause prescribing puberty blockers and hormones for patients under 18, citing the current regulatory environment as a significant factor behind the decision.
The institution stated, “This is not the decision we wanted to make… We stand firmly behind the fact that gender-affirming care is evidence-based, safe, and lifesaving.” This reflects the wider implications of the federal stance that deems transgender health care potentially harmful to children.
Dr. Scot Glasberg of the ASPS explained that the group’s recommendations followed long discussions, insisting these were not driven by political influences. He acknowledged the heightened ethical and legal risks involved in surgical decision-making regarding gender-affirming care, underscoring the complexity of the issue.
As the debate surrounding gender-affirming care continues to evolve, the conversation remains vital in understanding both the medical and ethical dimensions faced by providers and patients alike.
